Search jobs 11-May-2021 CORRECTING and REPLACING Former FDA and NIH Leader Dr. Vicki Seyfert-Margolis Joins Penrose TherapeuTx Scientific Advisory Board
Penrose scientific advisory board includes prominent research and regulatory experts in oncology, immunology and mitochondrial science
ANN ARBOR, Mich. & CHICAGO (BUSINESS WIRE) Please replace the release with the following corrected version due to multiple revisions in the first and third paragraphs, as well as correcting all instances of MyOwnMed to My Own Med, Inc. in the release text and image caption.
The corrected release reads:
FORMER FDA AND NIH LEADER DR. VICKI SEYFERT-MARGOLIS JOINS PENROSE THERAPEUTX SCIENTIFIC ADVISORY BOARD
Penrose scientific advisory board includes prominent research and regulatory experts in oncology, immunology and mitochondrial science
BioSpace Movers & Shakers, April 9 biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Published: Apr 09, 2021 By Alex Keown
Atara Biotherapeutics – Amie Krause was named Senior Vice President and Chief People Officer at Atara Biotherapeutics. In this role, Krause will be tasked with building a company culture that “rewards” values through actions and results. Prior to her tenure with Atara, Krause held several HR leadership positions at Amgen, including her role as Global HR Lead, Organizational Effectiveness during which she served as the human resources lead for Amgen’s global commercial operations covering the Americas, Europe, Asia, and the Middle East.
PsyBio Therapeutics – Michael Spigarelli was named chief medical officer of Ohio-based PsyBio. Before PsyBio Therapeutics, Spigarelli served as CMOr for Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases. Prior to that, he served as Vice President of Medical Affairs for Immucor, Inc., a leading provider of transfusion and tran
Al Drago/Bloomberg
PEOPLE UNDERESTIMATE AMOUNT OF SUPPORT FOR VACCINES AND MASK MANDATES, BOOTH FINDS: Businesses are underestimating the public s desire for stricter public health measures, according to a new study from the University of Chicago Booth School of Business that suggests that more restrictions may actually boost a company s bottom line.
In an experiment conducted by behavioral marketing professionals Oleg Urminsky and Abigail Bergman, 77 percent of participants surveyed said they d prefer to go to a hospital that required employee vaccinations over one that only recommended them. However, participants also underestimated how many people had the same preference, estimating that only 64 percent of the public would choose a hospital that requires employees vaccinations.